Amphastar Pharmaceuticals, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue171.2M183.1M191.8M174.4M170.5M186.5M188.8M182.4M
Cost of Goods Sold100.8M97.4M93.2M87.9M85.3M99.9M86.9M87.2M
Gross Profit70.3M85.7M98.6M86.5M85.3M86.6M101.9M95.2M
R&D Expenses26.7M23.3M22.4M20.1M20.1M18.1M21.1M17.7M
Operating Expenses56.7M50.1M73.3M44.3M48.0M41.5M44.9M39.9M
Operating Income13.6M35.6M25.3M42.2M37.3M45.1M57.0M55.2M
Other Income / Gains-3.6M-3.7M-3.8M-2.8M-6.4M-1.2M-9.4M-5.0M
Net Income6.4M24.4M17.4M31.0M25.3M38.0M40.4M37.9M
EPS (Diluted)0.140.530.380.660.530.780.830.78
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.4110.4680.5140.4960.500.4650.540.522
General And Administrative Expenses18.0M16.5M39.5M14.0M16.0M12.9M14.8M13.3M
Selling And Marketing Expenses11.9M10.3M11.5M10.2M11.9M10.4M9.0M9.0M
Selling General And Administrative Expenses30.0M26.8M51.0M24.2M27.9M23.4M23.8M22.3M
Other Expenses00000000
Cost And Expenses157.5M147.5M166.5M132.2M133.2M141.4M131.8M127.2M
Interest Income2.4M2.4M2.2M1.9M2.1M2.3M2.4M3.3M
Interest Expense6.6M6.6M6.3M6.3M6.3M6.4M6.7M8.6M
Depreciation And Amortization16.5M16.0M14.1M16.2M15.2M14.7M14.4M14.1M
Ebitda33.1M54.5M41.9M61.9M52.4M65.1M68.8M73.0M
Ebitdaratio0.1930.2980.2190.3550.3070.3490.3640.40
Operating Income Ratio0.080.1940.1320.2420.2190.2420.3020.303
Income Before Tax10.1M31.9M21.5M39.3M30.9M44.0M47.7M50.2M
Income Before Tax Ratio0.0590.1740.1120.2260.1810.2360.2530.275
Income Tax Expense3.6M7.5M4.2M8.3M5.6M6.0M7.3M12.3M
Net Income Ratio0.0380.1330.090.1780.1480.2040.2140.208
Epsdiluted0.140.510.370.640.510.740.780.73
Weighted Average Shs Out45.3M45.9M46.5M46.9M47.6M48.4M48.6M48.9M
Weighted Average Shs Out Dil46.5M47.2M47.7M48.1M49.9M52.1M51.9M52.0M